CLAZIDE

CLAZIDE

COMPOSITION

Each tablet contains :

– Gliclazide…………………………………………:30 mg

– Excipients : q.s………………………………..: 1 tablet

THERAPEUTIC PROPERTIES : 

Gliclazide is a sulfonylurea hypoglycemic agent and an oral antidiabetic. It stimulates insulin secretion.

INDICATIONS :

Non-insulin-dependent diabetes (type 2)

CONTRAINDICATIONS  :

• Known hypersensitivity to gliclazide or any of its components, to other sulfonylureas, or to sulfonamides;
• Type 1 diabetes;
• Severe renal or hepatic insufficiency.
• Treatment with miconazole.
• Breastfeeding

IN DOUBT CASE, IT IS ESSENTIAL TO SEEK THE ADVICE

FROM YOUR DOCTOR OR YOUR PHARMACIST

WARNING AND PRECAUTION :

Factors increasing the risk of hypoglycemia:

• Refusal or inability of the patient to cooperate (particularly in elderly individuals);
• Malnutrition, irregular meal times, skipped meals, fasting periods, or changes in diet;
• Imbalance between physical exercise and carbohydrate intake;
• Concurrent administration of other medications (see Interactions).

SIDE EFFECTS :

• The possible symptoms of hypoglycemia include: headaches, intense hunger, nausea, vomiting, fatigue, sleep disturbances, agitation, confusion, visual disturbances, and speech difficulties.
• Gastrointestinal disturbances, such as abdominal pain, dyspepsia, diarrhea, and constipation, have been reported.

DOSAGE AND ADMINISTRATION

 Oral administration.
For adults only.
The daily dose may range from 1 to 4 tablets, taken as a single oral dose at breakfast.

Initial dose:
The recommended initial dose is 1 tablet per day.

• If blood glucose control is satisfactory, this dosage can be maintained as the maintenance dose.
• If blood glucose control is not satisfactory, the dose may be increased to 2, 3, or 4 tablets per day.
  The maximum recommended dose is 4 tablets per day.